Explore more publications!

Press Releases

U.S. Department of Justice Announces Compensation Process for Victims of Chinese Liberal Education Holdings Ltd. (CLEU) Investment Fraud Scheme

U.S. Department of Justice Announces Compensation Process for Victims of Chinese Liberal Education Holdings Ltd. (CLEU) Investment Fraud Scheme

Noblie Expands Custom Blades Production and Catalog in U.S. Workshop
HedgeFusion Capital Releases 2026 Outlook: U.S. Equity-Crypto Link & "Dual Anchoring
M2i Global, along with Volato Group, in Collaboration with Nimy Resources Initiate First Shipment of High-Grade Gallium from Western Australia to U.S.
Vertex Report: U.S. Sees Record-Level Growth in Sales Tax Rates and Rules Changes in 2025 Amid Fiscal Uncertainty
Byonyks X1: Revolutinizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.
Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology
Myseum Granted and Issued U.S. Patent for Foundational Streaming and Content Sharing Technology
MAJOR SPORTING EVENT PLANNED VIEWERSHIP TRENDING UP IN 2026: 69% OF U.S. CONSUMERS PLAN TO WATCH SUPER BOWL LX, 58% OLYMPIC WINTER GAMES, 26% FIFA WORLD CUP, NUMERATOR REPORTS
Blackboxstocks Inc. (NASDAQ: BLBX) Merger Target REalloys Inc. and AltynGroup Kazakhstan Sign Series of Agreements to Secure Kazakhstan Rare Earth Feedstock for U.S. Government Defense Stockpiles
RADICL Secures $31M in Funding to Expand Its Autonomous Virtual SOC for SMBs Supporting U.S. Critical Infrastructure
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
TSC Life Receives FDA Clearance for Pediatric Use with Fluido® Compact System, a Blood & Fluid Warmer, in the U.S. and Canada
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
Blending American Research and Korean Skincare Methods Shapes New Approaches to Product Development
Mama Deals Helps Families Save Big With Daily Online Shopping Deals, Food Deals and Freebies
inHarmony Announces FDA Registration Across Vibroacoustic and Red Light Therapy Product Lines
Accelirate Announces the Launch of a New, Scalable Product for Denials and Appeals Management in Healthcare
EMS Named to Newsweek's America's Greatest Midsize Workplaces for Culture, Belonging & Community 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions